Copyright © 1983 by the European Society of Cardiology.
© 1983 The European Society of Cardiology
Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation
Istituto di Malattie dell'Apparato Cardiovascolare dell'Università degli Studi di Bologna Italy
Received 13 November 1981; revised 23 February 1982; .
Requests for reprints to: Dr Angelo Branzi, Istituto di Malattie dell Apparato Cardiovascolare dell' Università, Via Massarenti, 940138 Bologna, Italy.
Abstract
The hemodynamic effects of an acute infusion of prenalterol (PN), a new inotropic beta-adrenoceptor agonist, have been evaluated by cardiac catheterization in 10 patients with primary dilated (congestive) cardiomyopathy. A single dose of20µg/kg was administered over 5 min after basal hemodynamic and angiographic measurements. The administration of prenalterol caused a significant increase in mean cardiac index, from 2.3 to 3.3 l/min/m2 (P < 0.01) and mean stroke volume, from 47 to 62 ml (P < 0.01) without a change in heart rate. Mean left ventricular end-diastolic pressure was reduced from 19 to 13 mm Hg (P < 0.05) and left ventricular dp/dt rose from 902 to 1089 mm Hg/s (P < 0.01). Stroke work index increased from 27 to 40 gm/m2 (P < 0.01) and ejection fraction from 31 to 36% (P < 0.05). Mean blood pressure did not change and the systemic vascular resistance decreased from 24 to 17 RU (P < 0.01). The favorable effect of prenalterol on left ventricular relaxation was shown by an increase of peak negative left ventricular dp/dt from 946 to 1159 mm Hg/s and by a decrease of the time constant of left ventricular pressure fall from 49 to 39 s.
These results demonstrated a positive inotropic effect of prenalterol on patients with diffuse and severely reduced contractility.
Key Words: Prenalterol primary dilated cardiomyopathy heart failure therapy